Hungaropharma
Hungaropharma Zrt., a leading player in the pharmaceutical distribution industry, is headquartered in Hungary (HU) and operates extensively across Central and Eastern Europe. Founded in 1991, the company has established itself as a trusted partner in the healthcare sector, focusing on the distribution of pharmaceuticals, medical devices, and healthcare products. With a commitment to quality and innovation, Hungaropharma offers a diverse range of services, including logistics and supply chain management tailored to the needs of healthcare providers. The company is recognised for its robust market position, serving a wide network of pharmacies, hospitals, and healthcare institutions. Notable achievements include significant growth in operational capacity and strategic partnerships that enhance its service offerings, solidifying Hungaropharma's reputation as a cornerstone of the pharmaceutical landscape in the region.
DitchCarbon Score
How does Hungaropharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hungaropharma's score of 3 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hungaropharma's reported carbon emissions
Hungaropharma, headquartered in Hungary (HU), currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. Additionally, there are no documented reduction targets or climate pledges outlined in their available information. This absence of data suggests that Hungaropharma may still be in the early stages of formalising its climate commitments or reporting its emissions. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to set measurable targets for reducing greenhouse gas emissions. As such, Hungaropharma may benefit from establishing clear climate goals to align with industry standards and expectations.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hungaropharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
